Singapore markets closed

Elanco Animal Health Incorporated (ELAN)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
13.26+0.22 (+1.69%)
At close: 04:00PM EDT
13.25 -0.01 (-0.05%)
After hours: 05:16PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 6.55B
Enterprise value 11.97B
Trailing P/E N/A
Forward P/E 13.97
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.48
Price/book (mrq)1.05
Enterprise value/revenue 2.71
Enterprise value/EBITDA -53.45

Trading information

Stock price history

Beta (5Y monthly) 1.30
52-week change 338.13%
S&P500 52-week change 322.36%
52-week high 316.88
52-week low 37.88
50-day moving average 315.37
200-day moving average 313.07

Share statistics

Avg vol (3-month) 34.14M
Avg vol (10-day) 34.36M
Shares outstanding 5494.1M
Implied shares outstanding 6494.1M
Float 8490.51M
% held by insiders 10.64%
% held by institutions 198.82%
Shares short (15 Apr 2024) 415.52M
Short ratio (15 Apr 2024) 44.27
Short % of float (15 Apr 2024) 45.04%
Short % of shares outstanding (15 Apr 2024) 43.14%
Shares short (prior month 15 Mar 2024) 412.98M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -27.87%
Operating margin (ttm)1.64%

Management effectiveness

Return on assets (ttm)1.39%
Return on equity (ttm)-18.22%

Income statement

Revenue (ttm)4.42B
Revenue per share (ttm)8.97
Quarterly revenue growth (yoy)5.10%
Gross profit (ttm)N/A
EBITDA 973M
Net income avi to common (ttm)-1.23B
Diluted EPS (ttm)-2.50
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)352M
Total cash per share (mrq)0.71
Total debt (mrq)5.92B
Total debt/equity (mrq)95.07%
Current ratio (mrq)2.74
Book value per share (mrq)12.63

Cash flow statement

Operating cash flow (ttm)271M
Levered free cash flow (ttm)388M